IN PARTNERSHIP
allows us to deliver in a way that best reflects the needs of our clients of all sizes, and with projects of all scopes. We deliver proven, tailor-made Full Service solutions to both biotechs and pharmaceutical brands, enabling our sponsors to tap into a deep resource of expertise and talent to ensure a trial’s success. As a mid-sized CRO headquartered in Europe,
Excelya is uniquely placed in its ability to provide full-spectrum CRO services across three operating business models: Full Service, FSP and Resourcing. Operating on a fully flexible basis, with deep therapeutic and operational expertise, and partnering with best-in-class technology providers, Excelya offers clinical trial solutions that are designed around the needs of each assignments to scaleable teams, to Full Service clinical trial delivery.
Delivering excellence and long-standing partnerships, Excelya has grown to over 900 staff worldwide. Our operational and medical teams have decades of experience, and our track record of delivery has forged longstanding partnerships, with many of our key clients having worked with us for more than 10 years. We have achieved this by making excellence a part of our DNA and interweaving a genuine desire to improve patients’ lives into everything that we do. We also focus heavily on sustainability. We
scored highly in our environmental, social and governance (ESG) assessments and in 2022 we achieved a silver EcoVadis rating for the second
“Sponsors are looking for CROs that offer flexibility, in terms of operational delivery, patient recruitment strategies and technology all, cookie-cutter approach is no longer relevant”
year running. We are committed to continuing to improve our social and environmental impact.
Right-sized
The sponsor of tomorrow wants to feel like their study matters, and that it is in the right hands. Excelya’s global footprint, strong company culture and impressive use of technology solutions enable us to connect with a broad reach of patients and sites, and to establish strong local relationships and teams. Alongside this, we put a lot of emphasis on maintaining a human touch. We are proud to be a mid-sized CRO, personifying the sweet spot between remarkable resources, reach and quality of service and closeness to our clients and their projects. Our scaleable Resourcing and Functional
Services are built around our core centres of excellence, including Data Management, Biometrics, Medical Writing, Pharmacovigilance, eTMF and Clinical Monitoring. These can be ramped up quickly to respond to the needs of our partners or adjusted based on workload and demand.
Access to talent We are excited about the impending growth of our industry, and the much-awaited medicines and life-saving medical devices that it will bring. We are not intimidated; our people are passionate and driven to rise to the challenge. We have positioned ourselves to be exactly in the right place at the right time to meet the demand. By staying at the forefront of innovation, adapting to industry change, developing our unique operating model, nurturing our team members, and investing in training and our people development initiatives, Excelya team their careers and for clients to know that their clinical trial is being handled with care by experts who strive to deliver excellence. The consequence is a symbiotic relationship that is good for us, our team members, our clients, and patients.
For more information about how Excelya can help you realise your clinical trials goals and accelerate your drug or medical device approval, please email
contact@excelya.com.
Outsourcing in Clinical Trials Handbook | 63
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
